Synmosa Biopharma Corporation (TPEX:4114)
30.15
+0.10 (0.33%)
May 29, 2026, 1:30 PM CST
-3.04% (1Y)
| Market Cap | 15.16B +3.4% |
| Revenue (ttm) | 6.37B +11.4% |
| Net Income | 806.68M +13.6% |
| EPS | 1.60 +5.5% |
| Shares Out | 502.77M |
| PE Ratio | 18.79 |
| Forward PE | n/a |
| Dividend | 0.85 (2.82%) |
| Ex-Dividend Date | Jul 11, 2025 |
| Volume | 1,498,951 |
| Open | 30.05 |
| Previous Close | 30.05 |
| Day's Range | 29.95 - 30.15 |
| 52-Week Range | 30.00 - 39.80 |
| Beta | 0.00 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 11, 2026 |